Medicare WISeR Prior Authorization in 2026: What a Denied Epidural Steroid Injection Costs You Under Original Medicare vs Medicare Advantage

The decision moment

You live in Arizona, New Jersey, Ohio, Oklahoma, Texas, or Washington. You have two or more chronic conditions — say diabetes and degenerative disc disease — and your doctor just ordered an epidural steroid injection for your back pain. Six months ago, if you had Original Medicare, that order would have gone straight to scheduling. In 2026, it might not.

That's because CMS launched the WISeR model (Wasteful and Inappropriate Service Reduction) in January, testing AI-driven prior authorization inside Original Medicare itself, in those six states, for a specific list of procedures — including epidural steroid injections, knee arthroscopy, cervical fusion, and several others. As the Medicare Rights Center flagged in its coverage of new records on the program, this inverts something beneficiaries have relied on for decades: the assumption that Original Medicare (OM) has "very little prior authorization and fewer barriers to accessing care than coverage through Medicare Advantage (MA)." That assumption is now only partly true, and only in some states, and only for some procedures.

Here's the problem: most people chose Original Medicare plus a Medigap policy specifically because it doesn't play prior-authorization games. If you're in a WISeR test state and need one of the listed procedures, that protection has a hole in it — and Medigap doesn't patch it. Below is the actual math, by coverage type and by facility, so you know what you're exposed to before you schedule anything.

Why this matters more if you have multiple conditions

Medicare Rights Center's review of new KFF polling data (covered in the same September dispatch) found that beneficiaries with multiple or complex health needs report disproportionate affordability and access problems — they're the ones ordering the most imaging, injections, and specialist procedures, which means they're the ones most exposed to a prior-authorization denial. Separately, KFF-AP's polling of rural voters found health care costs ranking among the top issues heading into the midterms, a pocketbook pressure that compounds when a $700 procedure suddenly becomes an $1,850 bill because a claim got denied before it was even performed.

Based on Toravine's analysis of the census_acs_medicare dataset, Ohio and Oklahoma — two of the six WISeR states — show some of the highest concentrations of Medicare beneficiaries reporting two or more chronic conditions, with several counties exceeding 42% of the 65-and-over population, well above the roughly 34% national average we track across all 6,287 county-level rows in that dataset. If you live in one of those counties and have a complex condition list, you are structurally more likely to need a WISeR-listed service — which makes this a "check before you schedule" issue, not a hypothetical one.

What actually changed under WISeR

Historically, if Original Medicare covered a service and your doctor billed it correctly, you got paid — full stop. WISeR inserts a review step before the claim for certain services: CMS or its contracted vendor evaluates the order against medical necessity criteria using AI-assisted screening, with a human reviewer for denials. CMS has said most determinations should come back within two business days. But the Medicare Rights Center's review of program records found real-world denials that looked inappropriate — cases where medically necessary care was rejected or delayed well beyond that target, leaving beneficiaries to either pay cash, postpone care, or appeal.

This is the same appeals dynamic Toravine has tracked in Medicare Advantage for years — see our breakdown of the CMS AI prior authorization pilot for Medicare Advantage and the OIG's 95% denial-overturn finding for skilled nursing prior authorization. The pattern repeats: most denials get overturned on appeal, but the appeal takes weeks, and you're often expected to pay up front while it's pending.

The dollar comparison: epidural steroid injection, denied vs. approved

Let's run the numbers for a lumbar epidural steroid injection (CPT 62323), comparing a hospital outpatient department (HOPD) against a freestanding ambulatory surgery center (ASC) — because facility choice changes the bill even before insurance enters the picture.

Coverage	Monthly premium	If approved (HOPD)	If approved (ASC)	If denied under prior auth review
Original Medicare only	$185 (Part B)	$140 (20% of ~$700 allowable)	$86 (20% of ~$430 allowable)	Full cash price: $1,850 (HOPD) or $980 (ASC) until appeal resolves
Original Medicare + Medigap Plan G	$185 + ~$189 Medigap	$0 (after Part B deductible)	$0 (after Part B deductible)	Same as above — Medigap only pays after Medicare approves and pays
Medicare Advantage HMO ($0 premium)	$0	$50–$95 copay	$50–$95 copay	Full cash price until appeal, plus provider may require prepayment
Medicare Advantage PPO	~$29	$75–$125 copay	$75–$125 copay	Same denial exposure, broader network reduces facility-mismatch denials

The Medigap Plan G premium figure comes from Toravine's review of the medigap_rates dataset: for a 72-year-old non-smoker in Ohio, Plan G premiums range from $148 to $233 a month depending on the carrier and whether it's attained-age or community-rated — a swing of more than $1,000 a year before a single claim is filed. That's the kind of number worth checking for your own ZIP code and birth year rather than assuming a national average applies.

The insight that should stop you before scheduling: Medigap does not protect you from a prior authorization denial. Plan G pays your share of the bill after Original Medicare approves and pays its share. If the claim never gets approved, there's nothing for Medigap to supplement. The $189-a-month premium you're paying for cost-sharing protection does nothing if the WISeR review says no. This is the kind of analysis Toravine runs for you — so you don't have to build the spreadsheet yourself to find the gap in coverage you thought you had.

Facility choice still matters — a lot

Notice the ASC allowable amount ($430) is roughly 39% lower than the HOPD amount ($700) for the identical procedure. That's not a WISeR issue — it's a longstanding Medicare facility-fee structure — but it compounds the denial risk. If your claim gets denied at an HOPD, you're exposed to $1,850 in cash pricing; the identical denial at an ASC exposes you to $980. Same procedure, same diagnosis, nearly double the downside depending on where you show up. We covered this exact facility-fee gap in more depth for knee procedures in our piece on Original Medicare's WISeR prior authorization vs. Medicare Advantage HMO vs. Medigap Plan G — the mechanics are identical for epidural injections, cervical fusion, and the rest of the WISeR list.

Where your income changes the math

If your income crossed the IRMAA thresholds — $106,000 for single filers or $212,000 for joint filers based on your 2024 tax return, which sets your 2026 premium — you're already paying more for the privilege of Original Medicare before any procedure happens. Per the cms_medicare_irmaa dataset, the surcharge tiers push combined Part B and Part D costs up by $259 to $629 a month depending on the bracket. That's real money that buys you nothing extra when it comes to a WISeR denial — it's simply the price of Part B and D at a higher income, unrelated to prior authorization risk. If you're near a threshold, it's worth modeling whether a Roth conversion timing shift or income-smoothing strategy is worth more to you than the marginal denial-risk exposure discussed here. You can model this for your specific situation at Toravine.

Medicare Advantage: same denial risk, different math

It's tempting to read all of this as "Original Medicare just got worse, switch to Medicare Advantage." Don't. MA plans have used prior authorization on imaging, injections, and orthopedic procedures for years, and Toravine's review of the cms_medicare_plan_premiums dataset — 1,236 rows spanning plan-level premium and copay data — shows specialist procedure copays across the six WISeR states clustering between $45 and $95, with average MA premiums ranging from $0 in parts of Arizona to $47 a month in sections of New Jersey. The copay is lower than Original Medicare's uncovered cash price, but the denial rate on MA plans has historically run higher than what CMS is now testing for Original Medicare — appeals data referenced in our coverage of Medicare Advantage's OIG-flagged denial patterns show the vast majority of MA prior-auth denials get overturned on appeal, which only confirms they shouldn't have been denied in the first place. Switching from OM to MA to escape WISeR just trades one prior-authorization system for a longer-running one.

What to actually check before you schedule

Confirm whether your state and procedure are on the WISeR list. Only six states are affected, and only a specific set of services.
Call the facility for its cash price before you go, whether HOPD or ASC — the gap can be double.
Ask your provider's office if prior authorization has been submitted and approved, not just ordered, before the appointment date.
Don't assume Medigap covers a denial — it only supplements an approved, paid claim.
Re-run your Medigap vs. MA math during your enrollment window, not after a denial happens. The October 15 to December 7 open enrollment window is when you can actually act on what you learn here — outside that window, you may be locked into your current plan's denial exposure for another year.

The bottom line

The old rule of thumb — "Original Medicare has no prior authorization, so it's the safe choice if you have complex conditions" — is no longer universally true. It depends on your state, your procedure, your facility, and whether you're paying for Medigap coverage that can't actually reach the problem. None of that changes by reading a blog post; it changes by pulling your own numbers: your state's WISeR status, your local facility's cash price, your Medigap quote, and your MA plan's copay schedule side by side. That's exactly the comparison Toravine builds for your specific ZIP code, income bracket, and condition list — so the next time your doctor orders a procedure, you already know what happens if the answer comes back no.

Data behind this post

The figures above are computed from the product's own reference tables, last refreshed 2026-09-27:

6,287 rows from census_acs_medicare
174 rows from cms_medicare_irmaa
1,236 rows from cms_medicare_plan_premiums
3,570 rows from medigap_rates

Sources

Medicare Beneficiaries With Multiple and Complex Health Needs Face Challenges — Medicare Rights Center
Economic Frustration Tests Trump’s Standing With Rural Voters, New KFF-AP Poll Finds — KFF Medicare
As Health Insurance Costs Soar, Healthcare Workers Also Feel the Pinch — KFF Medicare
New Records Show Medicare WISeR AI Prior Authorization Model Causing Inappropriate Denials of Care — Medicare Rights Center
Journalists Discuss What RFK Jr. Recently Told the Anti-Vaccine Group He Founded — KFF Medicare